Small Stocks, Big Money™

XTI Aerospace (Nasdaq: XTIA) has appointed Palantir Technologies executive Hanna Tomory to its Corporate Advisory Board, bringing world-class expertise in AI, data platforms, and digital transformation to support the company’s next-gen TriFan 600 xVTOL program. As XTI pushes to integrate intelligent, adaptive systems across piloted and autonomous aircraft, Tomory’s leadership in deploying AI in mission-critical industries worldwide positions her as a key strategic asset in advancing XTI’s vision for smarter, more capable regional air mobility solutions.

Venu Holding Corporation (NYSE American: VENU) has partnered with Sands Investment Group, one of the nation’s fastest-growing net lease firms, to offer investors nationwide access to exclusive NNN Luxe FireSuite real estate opportunities with projected 11-12% cap rates. Structured as a “triple net lease” (NNN), this program provides predictable, hassle-free returns while capitalizing on the booming demand for premium seating in VENU’s upscale live entertainment venues.

FatPipe, Inc. (Nasdaq: FATN), a pioneer in secure, application-aware SD-WAN solutions, has announced its full executive team as it accelerates global expansion following its recent Nasdaq listing. Backed by industry veterans from AT&T, Reliance Datacomm, and more, FatPipe is poised to capture a share of the fast-growing $17.6 billion SD-WAN and SASE market by 2030, with new hiring and sales initiatives underway across the U.S., India, Southeast Asia, and Latin America.

bioAffinity Technologies (Nasdaq: BIAF) announced the release of a white paper highlighting real-world evidence of its CyPath® Lung test improving clinical decision-making in high-risk patients with indeterminate lung nodules. Featuring case studies from Dr. Gordon Downie, the report demonstrates how this noninvasive, AI-powered sputum test—proven 92% sensitive and 87% specific—helps physicians avoid unnecessary procedures while catching early-stage lung cancer when outcomes are most favorable.